Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

103 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group.
van Hoogstraten HJ, Vleggaar FP, Boland GJ, van Steenbergen W, Griffioen P, Hop WC, van Hattum J, van Berge Henegouwen GP, Schalm SW, van Buuren HR. van Hoogstraten HJ, et al. Among authors: van hattum j, van buuren hr, van berge henegouwen gp, van steenbergen w. Am J Gastroenterol. 2000 Aug;95(8):2015-22. doi: 10.1111/j.1572-0241.2000.02267.x. Am J Gastroenterol. 2000. PMID: 10950051 Clinical Trial.
Immunoglobulin A in the diagnosis of alcoholic liver disease.
van de Wiel A, van Hattum J, Schuurman HJ, Kater L. van de Wiel A, et al. Among authors: van hattum j. Gastroenterology. 1988 Feb;94(2):457-62. doi: 10.1016/0016-5085(88)90437-4. Gastroenterology. 1988. PMID: 2891587
Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP).
Janssen HL, Gerken G, Carreño V, Marcellin P, Naoumov NV, Craxi A, Ring-Larsen H, Kitis G, van Hattum J, de Vries RA, Michielsen PP, ten Kate FJ, Hop WC, Heijtink RA, Honkoop P, Schalm SW. Janssen HL, et al. Among authors: van hattum j. Hepatology. 1999 Jul;30(1):238-43. doi: 10.1002/hep.510300113. Hepatology. 1999. PMID: 10385662 Clinical Trial.
Reduction of relapse rates by 18-month treatment in chronic hepatitis C. A Benelux randomized trial in 300 patients.
Brouwer JT, Nevens F, Bekkering FC, Bourgeois N, Van Vlierberghe H, Weegink CJ, Lefebvre V, Van Hattum J, Henrion J, Delwaide J, Hansen BE, Schalm SW; Benelux Study Group On Treatment Of Chronic Hepatitis C. Brouwer JT, et al. Among authors: van hattum j, van vlierberghe h. J Hepatol. 2004 Apr;40(4):689-95. doi: 10.1016/j.jhep.2003.12.017. J Hepatol. 2004. PMID: 15030987 Clinical Trial.
Exogenous protoporphyrin inhibits Hep G2 cell proliferation, increases the intracellular hydrogen peroxide concentration and causes ultrastructural alterations.
Koningsberger JC, Rademakers LH, van Hattum J, de la Faille HB, Wiegman LJ, Italiaander E, van Berge Henegouwen GP, Marx JJ. Koningsberger JC, et al. Among authors: van hattum j, van berge henegouwen gp. J Hepatol. 1995 Jan;22(1):57-65. doi: 10.1016/0168-8278(95)80260-6. J Hepatol. 1995. PMID: 7751588
103 results